Animal models for hepatitis C

Eva K. Billerbeck, Ype De Jong, Marcus Dorner, Cynthia De La Fuente, Alexander Ploss

Research output: Chapter in Book/Report/Conference proceedingChapter

64 Citations (Scopus)

Abstract

Hepatitis C remains a global epidemic. Approximately 3 % of the world's population suffers from chronic hepatitis C, which is caused by hepatitis C virus (HCV) - a positive sense, single-stranded RNA virus of the Flaviviridae family. HCV has a high propensity for establishing a chronic infection. If untreated chronic HCV carriers can develop severe liver disease including fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Antiviral treatment is only partially effective, costly, and poorly tolerated. A prophylactic or therapeutic vaccine for HCV does not exist. Mechanistic studies of virus-host interactions, HCV immunity, and pathogenesis as well as the development of more effective therapies have been hampered by the lack of a suitable small animal model. Besides humans, chimpanzees are the only species that is naturally susceptible to HCV infection. While experimentation in these large primates has yielded valuable insights, ethical considerations, limited availability, genetic heterogeneity, and cost limit their utility. In search for more tractable small animal models, numerous experimental approaches have been taken to recapitulate parts of the viral life cycle and/or aspects of viral pathogenesis that will be discussed in this review. Exciting new models and improvements in established models hold promise to further elucidate our understanding of chronic HCV infection.

Original languageEnglish (US)
Title of host publicationHepatitis C Virus
Subtitle of host publicationFrom Molecular Virology to Antiviral Therapy
Pages49-86
Number of pages38
DOIs
StatePublished - Apr 29 2013
Externally publishedYes

Publication series

NameCurrent Topics in Microbiology and Immunology
Volume369
ISSN (Print)0070-217X

Fingerprint

Animal Hepatitis
Hepatitis C
Hepacivirus
Animal Models
Chronic Hepatitis C
Virus Diseases
Fibrosis
Flaviviridae
Genetic Heterogeneity
Pan troglodytes
RNA Viruses
Life Cycle Stages
Primates
Antiviral Agents
Liver Diseases
Hepatocellular Carcinoma
Immunity
Vaccines
Viruses
Costs and Cost Analysis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Microbiology (medical)
  • Immunology
  • Microbiology

Cite this

Billerbeck, E. K., De Jong, Y., Dorner, M., De La Fuente, C., & Ploss, A. (2013). Animal models for hepatitis C. In Hepatitis C Virus: From Molecular Virology to Antiviral Therapy (pp. 49-86). (Current Topics in Microbiology and Immunology; Vol. 369). https://doi.org/10.1007/978-3-642-27340-7-3

Animal models for hepatitis C. / Billerbeck, Eva K.; De Jong, Ype; Dorner, Marcus; De La Fuente, Cynthia; Ploss, Alexander.

Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. 2013. p. 49-86 (Current Topics in Microbiology and Immunology; Vol. 369).

Research output: Chapter in Book/Report/Conference proceedingChapter

Billerbeck, EK, De Jong, Y, Dorner, M, De La Fuente, C & Ploss, A 2013, Animal models for hepatitis C. in Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. Current Topics in Microbiology and Immunology, vol. 369, pp. 49-86. https://doi.org/10.1007/978-3-642-27340-7-3
Billerbeck EK, De Jong Y, Dorner M, De La Fuente C, Ploss A. Animal models for hepatitis C. In Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. 2013. p. 49-86. (Current Topics in Microbiology and Immunology). https://doi.org/10.1007/978-3-642-27340-7-3
Billerbeck, Eva K. ; De Jong, Ype ; Dorner, Marcus ; De La Fuente, Cynthia ; Ploss, Alexander. / Animal models for hepatitis C. Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. 2013. pp. 49-86 (Current Topics in Microbiology and Immunology).
@inbook{843dd7fe63044a9f87e60d2ddb48e5a1,
title = "Animal models for hepatitis C",
abstract = "Hepatitis C remains a global epidemic. Approximately 3 {\%} of the world's population suffers from chronic hepatitis C, which is caused by hepatitis C virus (HCV) - a positive sense, single-stranded RNA virus of the Flaviviridae family. HCV has a high propensity for establishing a chronic infection. If untreated chronic HCV carriers can develop severe liver disease including fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Antiviral treatment is only partially effective, costly, and poorly tolerated. A prophylactic or therapeutic vaccine for HCV does not exist. Mechanistic studies of virus-host interactions, HCV immunity, and pathogenesis as well as the development of more effective therapies have been hampered by the lack of a suitable small animal model. Besides humans, chimpanzees are the only species that is naturally susceptible to HCV infection. While experimentation in these large primates has yielded valuable insights, ethical considerations, limited availability, genetic heterogeneity, and cost limit their utility. In search for more tractable small animal models, numerous experimental approaches have been taken to recapitulate parts of the viral life cycle and/or aspects of viral pathogenesis that will be discussed in this review. Exciting new models and improvements in established models hold promise to further elucidate our understanding of chronic HCV infection.",
author = "Billerbeck, {Eva K.} and {De Jong}, Ype and Marcus Dorner and {De La Fuente}, Cynthia and Alexander Ploss",
year = "2013",
month = "4",
day = "29",
doi = "10.1007/978-3-642-27340-7-3",
language = "English (US)",
isbn = "9783642273391",
series = "Current Topics in Microbiology and Immunology",
pages = "49--86",
booktitle = "Hepatitis C Virus",

}

TY - CHAP

T1 - Animal models for hepatitis C

AU - Billerbeck, Eva K.

AU - De Jong, Ype

AU - Dorner, Marcus

AU - De La Fuente, Cynthia

AU - Ploss, Alexander

PY - 2013/4/29

Y1 - 2013/4/29

N2 - Hepatitis C remains a global epidemic. Approximately 3 % of the world's population suffers from chronic hepatitis C, which is caused by hepatitis C virus (HCV) - a positive sense, single-stranded RNA virus of the Flaviviridae family. HCV has a high propensity for establishing a chronic infection. If untreated chronic HCV carriers can develop severe liver disease including fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Antiviral treatment is only partially effective, costly, and poorly tolerated. A prophylactic or therapeutic vaccine for HCV does not exist. Mechanistic studies of virus-host interactions, HCV immunity, and pathogenesis as well as the development of more effective therapies have been hampered by the lack of a suitable small animal model. Besides humans, chimpanzees are the only species that is naturally susceptible to HCV infection. While experimentation in these large primates has yielded valuable insights, ethical considerations, limited availability, genetic heterogeneity, and cost limit their utility. In search for more tractable small animal models, numerous experimental approaches have been taken to recapitulate parts of the viral life cycle and/or aspects of viral pathogenesis that will be discussed in this review. Exciting new models and improvements in established models hold promise to further elucidate our understanding of chronic HCV infection.

AB - Hepatitis C remains a global epidemic. Approximately 3 % of the world's population suffers from chronic hepatitis C, which is caused by hepatitis C virus (HCV) - a positive sense, single-stranded RNA virus of the Flaviviridae family. HCV has a high propensity for establishing a chronic infection. If untreated chronic HCV carriers can develop severe liver disease including fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Antiviral treatment is only partially effective, costly, and poorly tolerated. A prophylactic or therapeutic vaccine for HCV does not exist. Mechanistic studies of virus-host interactions, HCV immunity, and pathogenesis as well as the development of more effective therapies have been hampered by the lack of a suitable small animal model. Besides humans, chimpanzees are the only species that is naturally susceptible to HCV infection. While experimentation in these large primates has yielded valuable insights, ethical considerations, limited availability, genetic heterogeneity, and cost limit their utility. In search for more tractable small animal models, numerous experimental approaches have been taken to recapitulate parts of the viral life cycle and/or aspects of viral pathogenesis that will be discussed in this review. Exciting new models and improvements in established models hold promise to further elucidate our understanding of chronic HCV infection.

UR - http://www.scopus.com/inward/record.url?scp=84876518168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876518168&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-27340-7-3

DO - 10.1007/978-3-642-27340-7-3

M3 - Chapter

C2 - 23463197

AN - SCOPUS:84876518168

SN - 9783642273391

T3 - Current Topics in Microbiology and Immunology

SP - 49

EP - 86

BT - Hepatitis C Virus

ER -